|
DE2848965A1
(de)
|
1978-11-11 |
1980-05-22 |
Behringwerke Ag |
Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine
|
|
US6699474B1
(en)
|
1990-08-20 |
2004-03-02 |
Erich Hugo Cerny |
Vaccine and immunserum against drugs of abuse
|
|
AU3630093A
(en)
|
1992-03-02 |
1993-10-05 |
Biocine S.P.A. |
Helicobacter pylori proteins useful for vaccines and diagnostics
|
|
NL9201716A
(nl)
|
1992-10-02 |
1994-05-02 |
Nederlanden Staat |
Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat.
|
|
FR2718452B1
(fr)
|
1994-04-06 |
1996-06-28 |
Pf Medicament |
Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
|
|
JPH10502365A
(ja)
|
1994-07-01 |
1998-03-03 |
リカン・リミテッド |
ヘリコバクタータンパク質およびワクチン
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
IL117483A
(en)
|
1995-03-17 |
2008-03-20 |
Bernard Brodeur |
MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
|
|
US6180111B1
(en)
|
1995-05-18 |
2001-01-30 |
University Of Maryland |
Vaccine delivery system
|
|
US6165774A
(en)
*
|
1995-09-22 |
2000-12-26 |
Connaught Laboratories Limited |
Parainfluenza virus glycoproteins and vaccines
|
|
EP0909323B1
(en)
|
1996-01-04 |
2007-02-28 |
Novartis Vaccines and Diagnostics, Inc. |
Helicobacter pylori bacterioferritin
|
|
CO4600681A1
(es)
*
|
1996-02-24 |
1998-05-08 |
Boehringer Ingelheim Pharma |
Composicion farmaceutica para la modulacion inmunitaria
|
|
AU753688B2
(en)
|
1997-03-10 |
2002-10-24 |
Ottawa Civic Loeb Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
AU7701098A
(en)
|
1997-05-28 |
1998-12-30 |
Michael A. Apicella |
Laft mutants of pathogenic gram-negative bacteria
|
|
GB9711964D0
(en)
|
1997-06-09 |
1997-08-06 |
Medical Res Council |
Live attenuated vaccines
|
|
DE69738472T2
(de)
|
1997-08-21 |
2009-01-02 |
De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur |
Neue mutanten der gram-negativen mukosalen bakterien und ihre verwendung als impfstoffe
|
|
DE19803453A1
(de)
*
|
1998-01-30 |
1999-08-12 |
Boehringer Ingelheim Int |
Vakzine
|
|
US6645503B1
(en)
|
1998-03-10 |
2003-11-11 |
Wyeth Holdings Corporation |
Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria
|
|
MX343752B
(es)
|
1998-05-01 |
2016-11-22 |
Novartis Vaccines & Diagnostics Inc |
Antigenos de neisseria meningitidis y composiciones que los contienen.
|
|
CA2347849C
(en)
|
1998-10-22 |
2013-06-25 |
The University Of Montana |
Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof
|
|
GB9823978D0
(en)
|
1998-11-02 |
1998-12-30 |
Microbiological Res Authority |
Multicomponent meningococcal vaccine
|
|
PT1127137E
(pt)
|
1998-11-03 |
2007-12-28 |
Staat Nl Verteg Door Min Welzi |
Lps com toxicidade reduzida a partir de bactérias gramnegativas modificadas geneticamente
|
|
NZ571167A
(en)
|
1999-04-30 |
2010-05-28 |
Novartis Vaccines & Diagnostic |
Fragments from Neisseria protein ORF 953 and their use in medicaments and diagnostic reagents
|
|
GB9918319D0
(en)
|
1999-08-03 |
1999-10-06 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
US6531131B1
(en)
|
1999-08-10 |
2003-03-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Conjugate vaccine for Neisseria meningitidis
|
|
WO2001034642A2
(en)
|
1999-11-12 |
2001-05-17 |
University Of Iowa Research Foundation |
Control of neisserial membrane synthesis
|
|
ATE460484T1
(de)
|
1999-11-29 |
2010-03-15 |
Novartis Vaccines & Diagnostic |
85 kda antigen von neisseria
|
|
ES2588917T3
(es)
|
2000-01-17 |
2016-11-07 |
Glaxosmithkline Biologicals Sa |
Vacuna de VME suplementada contra meningococo
|
|
AU2818101A
(en)
|
2000-01-25 |
2001-08-07 |
University Of Queensland, The |
proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
|
|
NO20002828D0
(no)
|
2000-06-02 |
2000-06-02 |
Statens Inst For Folkehelse |
Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav
|
|
HU228264B1
(en)
|
2000-06-08 |
2013-02-28 |
Intercell Ag |
Immunostimulatory oligodeoxynucleotides
|
|
ATE440861T1
(de)
|
2000-07-03 |
2009-09-15 |
Novartis Vaccines & Diagnostic |
Immunisierung gegen chlamydia pneumoniae
|
|
MXPA03000822A
(es)
|
2000-07-27 |
2004-11-01 |
Childrens Hosp & Res Ct Oak |
Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis.
|
|
GB0103170D0
(en)
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
AT410635B
(de)
|
2000-10-18 |
2003-06-25 |
Cistem Biotechnologies Gmbh |
Vakzin-zusammensetzung
|
|
GB0103171D0
(en)
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
FR2827605B1
(fr)
|
2001-07-20 |
2004-07-16 |
Pf Medicament |
Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin
|
|
CN100350972C
(zh)
*
|
2001-07-26 |
2007-11-28 |
启龙股份公司 |
含有铝佐剂和组氨酸的疫苗
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
ES2386386T3
(es)
|
2001-12-12 |
2012-08-20 |
Novartis Vaccines And Diagnostics S.R.L. |
Inmunización contra Chlamydia trachomatis
|
|
DE60325696D1
(de)
|
2002-02-22 |
2009-02-26 |
Ca Nat Research Council |
Synthese von lipopolysaccharid-protein konjugatvaccinen über die lipid-a region nach entfernung des glycosidischen phosphatresidüs
|
|
GB0211118D0
(en)
|
2002-05-15 |
2002-06-26 |
Polonelli Luciano |
Vaccines
|
|
GB0213622D0
(en)
|
2002-06-13 |
2002-07-24 |
Glaxosmithkline Biolog Sa |
Vaccine Corporation
|
|
CN1674933B
(zh)
|
2002-08-02 |
2012-09-26 |
葛兰素史密丝克莱恩生物有限公司 |
疫苗组合物
|
|
GB0220194D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
|
EP2351579B1
(en)
*
|
2002-10-11 |
2016-09-21 |
Novartis Vaccines and Diagnostics S.r.l. |
Polypeptide vaccines for broad protection against hypervirulent meningococcal lineages
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
AU2004224746B2
(en)
*
|
2003-03-24 |
2009-04-23 |
Valneva Austria Gmbh |
Improved vaccines
|
|
ES2351489T3
(es)
*
|
2003-03-24 |
2011-02-07 |
Intercell Ag |
Vacunas mejoradas.
|
|
WO2005002619A2
(en)
|
2003-06-26 |
2005-01-13 |
Chiron Corporation |
Immunogenic compositions for chlamydia trachomatis
|
|
GB0316560D0
(en)
|
2003-07-15 |
2003-08-20 |
Chiron Srl |
Vesicle filtration
|
|
WO2005084306A2
(en)
|
2004-03-02 |
2005-09-15 |
Chiron Corporation |
Immunogenic compositions for chlamydia pneunomiae
|
|
GB0419408D0
(en)
|
2004-09-01 |
2004-10-06 |
Chiron Srl |
741 chimeric polypeptides
|
|
GB0419627D0
(en)
|
2004-09-03 |
2004-10-06 |
Chiron Srl |
Immunogenic bacterial vesicles with outer membrane proteins
|
|
CN101107007B
(zh)
|
2005-01-27 |
2011-08-17 |
奥克兰儿童医院及研究中心 |
对脑膜炎奈瑟球菌所致疾病具有广谱保护作用的gna1870囊泡疫苗
|
|
AU2006214064B2
(en)
|
2005-02-18 |
2012-04-26 |
J. Craig Venter Institute, Inc. |
Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
|
|
JP2008530245A
(ja)
|
2005-02-18 |
2008-08-07 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド |
尿路病原性菌株由来の抗原
|
|
AU2006259858A1
(en)
|
2005-05-12 |
2006-12-28 |
Novartis Vaccines And Diagnostics S.R.L. |
Immunogenic compositions for Chlamydia trachomatis
|
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
|
WO2007110700A2
(en)
|
2005-12-22 |
2007-10-04 |
Novartis Vaccines And Diagnostics, Srl. |
Chlamydial antigens
|
|
WO2007071786A2
(en)
*
|
2005-12-23 |
2007-06-28 |
Glaxosmithkline Biologicals Sa |
Conjugate vaccines
|
|
ES2337309T5
(es)
|
2006-06-12 |
2013-07-30 |
Glaxosmithkline Biologicals S.A. |
Vacuna
|
|
EP2586790A3
(en)
|
2006-08-16 |
2013-08-14 |
Novartis AG |
Immunogens from uropathogenic Escherichia coli
|
|
CA2706617A1
(en)
*
|
2007-11-26 |
2009-06-25 |
Novartis Ag |
Adjuvanted glucans
|
|
EP2235532B1
(en)
|
2007-12-24 |
2013-04-24 |
Novartis AG |
Assays for adsorbed influenza vaccines
|
|
AU2009215364B2
(en)
|
2008-02-21 |
2014-09-18 |
Glaxosmithkline Biologicals S.A. |
Meningococcal fHBP polypeptides
|
|
ITMI20081249A1
(it)
|
2008-07-09 |
2010-01-09 |
Novartis Vaccines & Diagnostic |
Immunogeni di escherichia coli con solubilità migliorata.
|
|
NZ591768A
(en)
|
2008-09-18 |
2012-11-30 |
Novartis Ag |
Vaccine adjuvant combinations
|